Global private equity and venture capital news and research

Posts Tagged ‘Flagship Ventures’

27 March 2015

Healthcare-focused Flagship raises its biggest fund since 2000 with $537m close

flags-533821-m Massachusetts-based Flagship Ventures said it has nearly doubled the target for its fifth fund by closing the vehicle on $537m, bringing the firm’s aggregate funds under management to $1.4bn.

18 December 2014

Flagship launches Fund V with $350m target

US flag at Pearl Harbor US venture capital firm Flagship Ventures is looking to raise its biggest fund to date with the launch of Fund V targeting $350m, AltAssets can reveal.

15 October 2014

Polaris, Flagship Ventures among backers in $20m Selecta Biosciences round

biotech lab clinic research Immune therapy business Selecta Biosciences has picked up more than $20m of new financing from a host of venture capital investors.

3 October 2014

Merck, Vertex and Temasek lead $30m round in Visterra

Visterra Merck Research Labs Venture Fund, Vertex Venture Holdings and Temasek have co-led a $30m Series B financing round in biotechnology company Visterra.

26 August 2014

Flagship Ventures hires Swiss consulting firm co-owner, agri expert as venture partner

RobBerendes Healthcare-focused early-stage investment firm Flagship Ventures has hired Swiss consulting firm co-owner and partner Robert Berendes as a venture partner.

13 August 2014

VC-backed blood diagnostics business picks up $16m Series B round

blood drop Venture capital-backed blood collection and diagnostic business Seventh Sense Biosystems has picked up $16m of Series B financing.

15 July 2014

Flagship brings aboard ex-Merck & Co exec Pomerantz as senior partner

Roger Pomerantz Flagship Ventures Healthcare-focused early stage investment firm Flagship Ventures has hired former Merck & Co senior vice president Roger Pomerantz as a senior partner.

18 February 2014

Flagship-founded food nutrion developer Pronutria gets $12.25m Series B

microscope7_sq Flagship Ventures has led a $12.25m Series B financing round for nutrition supplement and medical food-developer Pronutria.

7 February 2014

Eleven Biotherapeutics raises $50m via IPO

dollar envelope money Venture capital-backed biopharmaceutical company Eleven Biotherapeutics has raised $50m via an IPO on the Nasdaq exchange.

25 November 2013

Flagship, Polaris, Third Rock lead $43m Series A for Editas Medicine

biotech_lrg Flagship Ventures, Polaris Partners and Third Rock Ventures have led a $43m Series A for genome editing specialist Editas Medicine.

Page 1 of 212

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015